- Home
- ENTX vs SHMD Comparison
ENTX vs SHMD Comparison
Compare ENTX & SHMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTX
- SHMD
- Stock Information
- Founded
- ENTX 2010
- SHMD 1864
- Country
- ENTX Israel
- SHMD Germany
- Employees
- ENTX N/A
- SHMD N/A
- Industry
- ENTX Biotechnology: Biological Products (No Diagnostic Substances)
- SHMD
- Sector
- ENTX Health Care
- SHMD
- Exchange
- ENTX Nasdaq
- SHMD Nasdaq
- Market Cap
- ENTX 104.0M
- SHMD 123.6M
- IPO Year
- ENTX 2018
- SHMD N/A
- Fundamental
- Price
- ENTX $1.83
- SHMD $3.41
- Analyst Decision
- ENTX Strong Buy
- SHMD
- Analyst Count
- ENTX 1
- SHMD 0
- Target Price
- ENTX $10.00
- SHMD N/A
- AVG Volume (30 Days)
- ENTX 32.7K
- SHMD 23.4K
- Earning Date
- ENTX 08-08-2025
- SHMD 02-25-2025
- Dividend Yield
- ENTX N/A
- SHMD N/A
- EPS Growth
- ENTX N/A
- SHMD N/A
- EPS
- ENTX N/A
- SHMD N/A
- Revenue
- ENTX $223,000.00
- SHMD $85,165,542.00
- Revenue This Year
- ENTX N/A
- SHMD N/A
- Revenue Next Year
- ENTX N/A
- SHMD N/A
- P/E Ratio
- ENTX N/A
- SHMD N/A
- Revenue Growth
- ENTX N/A
- SHMD N/A
- 52 Week Low
- ENTX $1.41
- SHMD $1.86
- 52 Week High
- ENTX $2.79
- SHMD $4.98
- Technical
- Relative Strength Index (RSI)
- ENTX 39.81
- SHMD N/A
- Support Level
- ENTX $1.84
- SHMD N/A
- Resistance Level
- ENTX $2.02
- SHMD N/A
- Average True Range (ATR)
- ENTX 0.13
- SHMD 0.00
- MACD
- ENTX -0.02
- SHMD 0.00
- Stochastic Oscillator
- ENTX 7.89
- SHMD 0.00
About ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
About SHMD SCHMID Group N.V. Class A Ordinary Shares
Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).